Activation of signal transducer and activator of transcription (STAT) pathways in failing human hearts.
暂无分享,去创建一个
[1] Daniel Nathans,et al. Specific Ablation of Stat3β Distorts the Pattern of Stat3-Responsive Gene Expression and Impairs Recovery from Endotoxic Shock , 2002, Cell.
[2] L. Wold,et al. Abrogated Leptin-Induced Cardiac Contractile Response in Ventricular Myocytes Under Spontaneous Hypertension: Role of JAK/STAT Pathway , 2002, Hypertension.
[3] Y. Takeishi,et al. Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy. , 2002, Cardiovascular research.
[4] K. Nakao,et al. Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy. , 2001, Journal of the American College of Cardiology.
[5] N. Maulik,et al. Role of STAT3 in ischemic preconditioning. , 2001, Journal of molecular and cellular cardiology.
[6] D. Kass,et al. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[7] D. Hilton,et al. Negative regulation of cytokine signaling , 2001, Journal of leukocyte biology.
[8] Y. Fujio,et al. Activation of Signal Transducer and Activator of Transcription 3 Protects Cardiomyocytes from Hypoxia/Reoxygenation-Induced Oxidative Stress Through the Upregulation of Manganese Superoxide Dismutase , 2001, Circulation.
[9] P. Gabriele,et al. Activation of the cardiac interleukin‐6 system in advanced heart failure , 2001 .
[10] G. Sandusky,et al. Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK alpha is the predominant isoform expressed in human heart. , 2001, Journal of molecular and cellular cardiology.
[11] R. Bolli,et al. An essential role of the JAK-STAT pathway in ischemic preconditioning , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] R. Knight,et al. Induction of Apoptosis and Fas Receptor/Fas Ligand Expression by Ischemia/Reperfusion in Cardiac Myocytes Requires Serine 727 of the STAT-1 Transcription Factor but Not Tyrosine 701* , 2001, The Journal of Biological Chemistry.
[13] Y. Hiroi,et al. gp130 Plays a Critical Role in Pressure Overload-induced Cardiac Hypertrophy* , 2001, The Journal of Biological Chemistry.
[14] Z. Xia,et al. Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia. , 2001, Leukemia research.
[15] R. Ilaria,et al. STAT isoforms: mediators of STAT specificity or leukemogenesis? , 2001, Leukemia research.
[16] G. Christensen,et al. Myocardial gene expression of leukaemia inhibitory factor, interleukin‐6 and glycoprotein 130 in end‐stage human heart failure , 2001, European journal of clinical investigation.
[17] R. Hajjar,et al. Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure , 2001, Circulation.
[18] S. Beppu,et al. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats. , 2001, Journal of molecular and cellular cardiology.
[19] R. Kitsis,et al. The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice , 2000, The EMBO journal.
[20] D. Mann,et al. Cytokines as emerging targets in the treatment of heart failure. , 2000, Trends in cardiovascular medicine.
[21] Y. Fujio,et al. Signal Transducer and Activator of Transcription 3 Is Required for Glycoprotein 130-mediated Induction of Vascular Endothelial Growth Factor in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.
[22] M. Okabe,et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] E. Olson,et al. From the sarcomere to the nucleus: role of genetics and signaling in structural heart disease. , 2000, Annual review of genomics and human genetics.
[24] K. Chien,et al. Stress Pathways and Heart Failure , 1999, Cell.
[25] S. Cook,et al. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. , 1999, Journal of molecular and cellular cardiology.
[26] A. Zauberman,et al. Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3 , 1999, Oncogene.
[27] W. Feniuk,et al. Activated G Protein-coupled Receptor Induces Tyrosine Phosphorylation of STAT3 and Agonist-selective Serine Phosphorylation via Sustained Stimulation of Mitogen-activated Protein Kinase , 1999, The Journal of Biological Chemistry.
[28] L. Ivashkiv,et al. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] Y. Fujio,et al. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. , 1998, Circulation.
[30] M. Siddiqui,et al. Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] Y. Fujio,et al. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. , 1996, Circulation.
[32] Jerrold M. Olefsky,et al. Protein-tyrosine Phosphatase 1B Is a Negative Regulator of Insulin- and Insulin-like Growth Factor-I-stimulated Signaling* , 1996, The Journal of Biological Chemistry.
[33] J. Lammers,et al. STAT3β, a Splice Variant of Transcription Factor STAT3, Is a Dominant Negative Regulator of Transcription* , 1996, The Journal of Biological Chemistry.
[34] J. Ihle. Cytokine receptor signalling , 1995, Nature.
[35] Jiahuai Han,et al. Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.
[36] Andrew Ziemiecki,et al. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins , 1993, Nature.
[37] J. Darnell,et al. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. , 1993, Science.
[38] W. Fantl,et al. Signalling by receptor tyrosine kinases. , 1993, Annual review of biochemistry.